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CHAPTER I 
 
INTRODUCTION 
 
Motivation 
 An increasing number of molecular biomarkers are used in diagnostic procedures 
for a wide variety of diseases like influenza, SARS, pneumonia, cancer, and even heart 
disease.  The need for rapid methods to detect low concentrations of biomarkers is 
becoming more critical.  However, current methods of detection often fail when a 
biomarker is present at low concentrations, potentially leading to situations where a 
biomarker is not detected (false negative) or a biomarker is incorrectly identified as being 
present (false positive).  Building detection platforms that provide sensitive, reliable, 
rapid, and quantitative identification of biomarkers would improve the prospects for 
earlier detection and the timely implementation of the correct course of treatment. 
In many detection applications, antibodies are used as the initial detector interface 
due to their plasticity and very high specificity.  Enzyme-linked immunosorbent assays 
(ELISA) are the gold standard of antibody-based detection technologies.1  More sensitive 
methods, like immuno-polymerase chain reactions (IPCR) and antibody-nanoparticle-
DNA reporter tag assays have also been developed.2, 3  However, a drawback of highly 
sensitive antibody-based detection technologies is the innate presence of non-specific 
interactions between antibodies and undesired targets, leading to false positives.   
The detection platform described in this thesis combines two aspects of previous 
work, DNA reporter tags and DNA computing, to control for non-specific antibody-
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antigen interactions by performing a Boolean NOT operation using nanoparticle surface 
structures, which we call DNA logic tags.  The basic idea of this approach is illustrated in 
Figure 1 and Figure 2 (Chapter II), which describe the two steps: formation of an ELISA-
like antibody-antigen complex (Figure 1) and the implementation of a logical NOT 
operation (Figure 2). 
As shown in Figure 1, a unique DNA logic tag sequence, e.g. A (red line in the 
upper left), is hybridized to DNA bound to gold nanoparticles.  DNA logic tag A is 
associated with a specific antibody (red branched structure) since they are both 
conjugated to a gold nanoparticle.  Combining this with an antibody-magnetic bead 
construct, antibody binding to target results in an ELISA-like sandwich and delivery of 
the DNA tag to an analyte solution.  In addition to the gold nanoparticles conjugated to 
specific antibody and its unique DNA logic tag A (red), a second gold nanoparticle is 
added to the antigen test solution, which is coupled to a matched non-specific antibody 
and DNA logic tag A' (green).  Although the second antibody is not specific to the target, 
it may become entrapped non-specifically in the magnetic pulldown complex; this 
entrapment mirrors any non-specific entrapment of the specific antibody in the magnetic 
pulldown complex.  Sequence A and A' are designed to enable logical operations among 
tags.  In this approach, they can be used to perform tag subtraction to remove non-
specific antibody interactions. 
Figure 2 describes how the NOT operation is used to subtract non-specific 
binding events prior to amplification by PCR.  DNA logic tag A is designed with a 
restriction enzyme site and tag A' contains the complementary site.  After being released 
from gold nanoparticles, the tags' complementary regions hybridize.  A restriction 
 2
enzyme is then used to cleave hybridized A-A'.  Figure 2 illustrates the case when tag A 
is delivered in excess of tag A', which should occur if antibody targets are present in the 
analyte solution.  Restriction enzyme digestion reduces the number of copies of A, but 
remaining A is amplified by PCR to indicate the presence of target.  If the two antibodies 
are matched with respect to their non-specific binding characteristics, then the reduction 
in the number of copies of tag A should account for non-specific binding from the 
specific antibody.  This will serve to reduce the likelihood of generating a false positive 
due to non-specific binding. 
In the following pages, traditional, DNA-DNA-based, and antibody-based 
detection methods are reviewed and tied into recent advances in pathogen detection 
methods, such as DNA reporter tags.  In addition to these topics, DNA computing is also 
discussed, including Adleman's pioneering work and the latest advances in DNA 
nanomachines, Boolean control, and logic circuits. 
 
Traditional Methods of Virus Detection 
 Standard techniques of pathogen detection rely on the growth of the organism in 
cell culture or replication of virus in a suitable host.  While this remains the gold standard 
for the identification of many viruses, such as respiratory viruses found in nasal 
secretions, it is an expensive procedure requiring a high level of expertise.  Also, the 
process, which includes purification of the virus prior to testing, can take days to months 
depending upon what needs to be detected.4, 5  This application is not practical in 
situations where accurate results are rapidly needed.6 
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 Another way to detect viral products is on the basis of their chemical structures.  
Traditional analytical chemistry tools, such as gas chromatography-mass spectrometry, 
can lead to very precise and highly sensitive analyses.  However, they are not procedures 
that can easily be introduced into most laboratories as large and expensive equipment is 
needed.  Also, this method cannot be easily applied to intricate target analytes such as 
bacteria.6  These complexities can be solved by identifying specific signature 
components, but this approach is generally too elaborate for routine and rapid analysis.7 
 Two significant advances have had a profound effect on the speed, specificity, 
and sensitivity of pathogen detection: (1) recombinant DNA technology, with the 
development of polymerase chain reaction (PCR) as the key event and (2) methods to 
generate monoclonal antibodies.6 
 
Molecular Recognition Mediated by DNA-DNA Interactions 
 Any self-replicating biological entity (except prions which do not have nucleic 
acids associated with them) can be discriminated on the basis of nucleic acid sequences 
unique to that particular organism.8  If enough effort has been put into identifying unique 
sequences that correspond to different viruses, then an assay utilizing nucleic acid-based 
detection techniques can be used.  Sequences are usually determined by chain-
termination methods which use PCR with radiolabeled dNTPs and dideoxynucleotides to 
terminate the replication process.  Primers can be developed by replicating fragments of 
the DNA of interest in bacteria.  However, there is a fine line between creating a very 
specific assay and making assays that are more inclusive to recognize viral variants.6 
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Direct Sequence Detection 
 One category of nucleic acid-based detection is direct target probing with signal 
amplification.  The basis of these assays is the ability of complementary nucleic acid 
strands to form stable hybrid complexes.  These strands anneal to one another by 
adhering to Watson-Crick rules of base pairing.  The stability of these complexes is 
highly correlated with the melting temperature (Tm) or the temperature at which half of 
the hybrid complexes are disassociated.  In general, Tm is equivalent to the sum of 2°C 
for each adenine-thymine (A-T) base pair and 4°C for each guanine-cytosine (G-C) base 
pair.  Other factors also play a role in the stability of the hybrid complex: ionic 
concentration, pH, length of the complementary sequence, and any mismatches between 
the strands.6 
 Typically, two probes, complementary to different areas of the target of interest, 
are designed.  One probe is immobilized to a solid support and serves to capture the 
nucleic acid target.  After washing steps are completed, a second probe labeled with a 
reporter molecule binds to a spatially distinct portion of the target to detect bound target.  
Since most target nucleic acids are pieces of genomic DNA recovered from biological 
sources, they are double-stranded and need to be denatured by alkali or heat treatment 
before hybridization with respective probes.6  
 The reporter can be a variety of molecules, such as radioisotopes, fluorophores, 
enzymes, or haptens.  Radioisotopes were the first molecule utilized within this 
application, but they are not favored due to their limited half-life, potential toxic effects, 
and handling concerns.6  Although directly labeling the immobilized probe with an 
enzyme or a fluorophore eliminates post-hybridization steps, it can also limit the 
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performance of a probe due to negative effects on diffusivity and increasing steric 
hindrance during hybridization.  Labeling with haptens and low molecular weight 
molecules is frequently used to circumvent these issues.  One example is biotin-
streptavidin: biotin is used to label the probe and a secondary reagent, in this case, a 
streptavidin-enzyme complex, is added to bind to the biotinylated signal probe to detect 
the presence of target.  Another system uses digoxigenin-labeled probe which binds an 
anti-digoxigenin antibody-enzyme complex.6 
 Chromogenic substrates are also utilized as reporter molecules.  The hydrolysis 
product is insoluble and can be used for simple visual assays.  In general, a color change 
is observed and scored visually using a spectrophotometer.  The main advantage of using 
colorimetric assays is that the spectrophotometer needed can be small, hand-held, and 
battery-powered with digital readout and programmable threshold settings to score assays 
automatically.  Sensitivity can be increased by using fluorogenic or chemiluminescent 
substrates, although they cannot be scored visually and require instrumentation that is not 
presently available as hand-held models.6 
 Examples of direct sequence detection methods include branched DNA and 
photolithographically generated oligonucleotide arrays.  Branched DNA (Chiron 
Corporation, Emeryville, CA) uses sequential hybridization of sets of probes resulting in 
104-fold signal amplification and detection of as low as 103 copies of target DNA.9, 10  
GeneChips (Affymetrix, Santa Clara, CA) contain carefully designed and spatially 
arranged DNA probes in arrays.  Fluorescently labeled targets are identified when they 
hybridize to complementary probes.  Fluorescence imagers, like gene array scanners or 
charge-coupled device (CCD) cameras, are then used to visualize any captured DNA.  
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Also, detecting nucleic acids by direct hybridization methods has been reported using 
CCDs, light addressable potiometric sensors, and evanescent wave sensors.6 
 Although the methods discussed above are quite straightforward and simple to 
perform, they are also time-consuming and require pre-hybridization sample preparation.  
Furthermore, due to the lack of amplification steps, hybridization-based assays are 
limited in terms of sensitivity.  Most DNA-based systems require at least 105 – 106 targets 
in order to produce a positive result.6 
 
Target Amplification 
 As mentioned above, the need for high concentrations of initial target is a 
disadvantage of direct sequence detection.  This problem can be overcome by amplifying 
the target which effectively increases the number of targets prior to using one of the 
detection techniques described above.  This additional step has greatly improved direct 
sequence detection.  In fact, a number of post-amplification detection systems have been 
developed which only rely on initial target amplification.   
 The development of PCR revolutionized nucleic acid-based diagnostics.  By 
utilizing DNA polymerases that are only active at an increased temperature (for example: 
Thermus aquaticus DNA polymerase), a target region of nucleic acid, defined by a set of 
oligonucleotide primers, is amplified.11, 12  One of the key features of PCR is that each 
newly formed strand becomes a suitable template if the product contains the primer-
binding site.6   
 Applying PCR to detection methods has taken many forms.  First, if a viral 
genome is RNA based, direct amplification by PCR can be used if reverse transcription is 
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first applied to convert RNA to DNA.  Second, coupling PCR to any nucleic acid-based 
detection system results in a significant increase in assay sensitivity.  Many of the 
techniques described above can successfully incorporate PCR as a step prior to detection.   
 PCR output can be evaluated using a variety of methods.  The final product from 
PCR is detected by agarose or polyacrylamide gel electrophoresis and the addition of an 
intercalating dye like ethidium bromide or a fluorescent marker that attaches to double-
stranded DNA.  The result is used to check for molecular weight and to approximate the 
amount of product formed by measuring the intensity of the band. 
A more quantitative approach takes advantage of real-time PCR.  This process 
requires no post-PCR sample handling as the PCR product is evaluated in real-time 
during the PCR process using a machine that not only cycles through various 
temperatures, but also contains a light emitter and detector to measure fluorescence.13  An 
intercalating dye, like fluorescein, which binds to double-stranded product and measures 
increases in fluorescence when DNA is replicated, is added to the initial PCR mix.  The 
outcome can then be compared to a standard linear curve to obtain a quantitative result.14  
Newer technologies like TaqMan Probes, which take advantage of the 5' nucleolytic 
activity of DNA polymerase, release a fluorescent marker every time the probe is 
incorporated into a newly formed DNA strand, enabling more accurate fluorescence 
readings.6 
 One disadvantage of this technique is that it remains laboratory-based and 
requires the services of skilled personnel.  While it has been promising initially, it is not 
extremely rigorous yet and still requires further development in measuring final product 
with relative certainty.  
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 Ligase chain reactions are similar to PCR, but have been developed to 
discriminate between targets that differ in only a single base pair.  A single base pair 
difference could mean the difference among the formation of normal, abnormal, and non-
functional proteins.  Ligation detection reactions are based on the use of two adjacent 
oligonucleotides designed so that the junction between the 3' end of upstream and 
downstream primers coincides with the nucleotide that distinguishes one type of target 
from another.6, 15  DNA ligase seals the nick between the two oligonucleotides only if the 
3' end of one primer is complementary to the target.  Therefore, if the two 
oligonucleotides are ligated, a positive reaction has occurred and the correct target is 
present.  This ligated product can then serve as a template for another round of ligation, 
leading to a 2-fold increase in the number of templates.  While this process is not as 
robust as PCR, ligase chain reactions are still amplification-based and more specific.6 
 One limitation of both PCR and ligase chain reactions is that they require a 
thermocycler to quickly change temperatures in order to effect the enzymes involved and 
allow the reaction to progress.  
 
Molecular Recognition Mediated by Antibody-Based Interactions 
 Immunological detection uses antibodies to detect any chemical compound that 
can trigger an immune response.  Antibodies to larger molecules like proteins can be 
made by immunizing an animal with an injection of molecules; antibodies to small 
molecules that would normally not trigger an immune response are generated by 
conjugating the smaller molecules to an immunogenic substance before immunizing.  
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Over time, the antibodies produced by an animal tend to have an increased affinity for the 
antigen. 
 
Polyclonal and Monoclonal Antibodies  
 The entire population of antibodies observed in the serum of an immunized 
animal is termed polyclonal.  These antibodies recognize all antigens to which the animal 
has been exposed to in the past.  The specific antigenicity of the compound used to 
immunize the animal determines how many of the antibodies will be directed against the 
specific antigen.  The main disadvantage of polyclonal antibodies is that they are limited 
in terms of their specificity due to the presence of cross-reacting antibodies.  Sometimes 
the desired antibodies can be separated by affinity chromatography using an immobilized 
antigen or by selective absorption of cross-reacting antibodies using an extract prepared 
from the cross-reactive materials.  Another drawback is that polyclonal antibodies are not 
as abundant as monoclonal antibodies as they are limited to the lifespan of the animal and 
the amount of serum that can be collected from them.  For polyclonal antibodies, 
antibody-producing cells cannot be directly cultured outside of an animal since they are 
not transformed and therefore not immortal.6 
 A technological advance in 1975 allowed antibody-producing cells to be grown in 
culture by fusion with a transformed cell line, granting immortality to the new cell line.16  
Antibody-producing B cells and tumor cells were genetically fused to produce a 
hybridoma which continues to secrete antibody.  Now, individual lines can be cultured as 
well as selected for by assaying against the desired antigen; this decreases the presence of 
cross-reacting antibodies.  
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Enzyme-Linked Immunosorbent Assays 
 One of the most powerful and most commonly used methods for molecular 
detection using antibodies is enzyme-linked immunosorbent assays (ELISA).  This 
approach uses enzymes as labels for antibodies.  The enzymes are linked to antibodies 
such that the complexes have both immunological and enzymatic activities.  The 
enzymes degrade chromogenic or fluorogenic substrates, yielding accurate and sensitive 
detection of the presence of enzyme.  First, a polyclonal or monoclonal antibody is 
adsorbed to the surface of a plate.  Then, a solution containing the antigen of interest is 
added, followed by a series of washing and blocking steps.  Next, a different monoclonal 
antibody labeled with an enzyme is added, followed by the enzyme substrate.  The 
amount of antigen present is correlated to the amount of substrate hydrolyzed, measured 
by a spectrophotometer or a fluorimeter and compared to a reference negative sample and 
a standard curve.1 
 One disadvantage of ELISA is that not all antibodies can be used – monoclonal 
antibodies must be qualified as matched pairs, meaning they must recognize separate 
epitopes on the antigen so they do not hinder each other's binding.  Also, there is a limit 
to its sensitivity since the amplification is restricted by the amount of enzyme that can be 
conjugated to antibodies.  Immunoreactivity of the antibody may be reduced by enzyme 
labeling, which in itself is an expensive and time-consuming process. 
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Recent Advances in Antibody-Based Detection Methods 
 Current improvements in pathogen detection have attempted to combine the 
specificity of antibody-based detection methods with the sensitivity of nucleic acid-based 
amplification procedures.  Additionally, in order to increase the sensitivity of detection 
applications, many nanoscale processes have been developed for the evaluation and 
recognition of pathogenic particles.  
 
Immuno-Polymerase Chain Reaction 
 The goal of immuno-polymerase chain reactions (IPCR) is to combine nucleic-
acid amplification techniques with conventional antibody-based immunoassays to 
enhance their sensitivity.17  In 1992, Sano, et al., introduced chimeric conjugates of 
specific antibodies and nucleic acids in IPCR, with the nucleic acids used as markers to 
be amplified by standard PCR to generate signal.2  The advantage of this process is the 
efficiency from nucleic acid amplification, which can lead to a 100 – 10,000–fold 
increase in sensitivity, while still maintaining the precision and robustness of the initial 
antibody-based assay.  The more recent development of efficient reagents, the design of 
assay formats, and the maintenance of functionality, even within complex biological 
matrices have greatly improved the sensitivity and flexibility of IPCR.17 
 The most prominent obstacle in IPCR is the high background signals that often 
prohibit meaningful results.  Although some noise has been reduced through the use of 
appropriate blocking protocols, preformed reagents, and optimized antibodies, the 
problem is still a large limitation of this method. 
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Antibody-Particle-DNA Reporter Tag Assay 
 This assay is another powerful detection and amplification system that can be 
applied to detect nucleic acids and proteins.3  Two types of particles are used to 
accomplish sample purification, detection, and amplification.  The first is a microparticle 
with a recognition agent, either an oligonucleotide complementary to the DNA target or a 
polyclonal antibody.  The second is a nanoparticle conjugated to an oligonucleotide 
complementary to another part of the target DNA or a monoclonal antibody.  This 
nanoparticle also carries hundreds of oligonucleotides referred to as bar-codes, which are 
15 - 20-mer oligonucleotides.  Once the two particles have sandwiched a target, a 
magnetic field is used to separate the complexed target and bound nanoparticles from the 
sample solution.  The bar-codes are released by heating the solution or by adding a 
reducing agent such as dithiothretiol.18, 19  The bar-codes are then identified with a high 
sensitivity detection system.  Scanometric machines, in situ fluorescence-based 
approaches, and PCR have all been used as the high sensitivity readout mechanism.  
Although the bio-bar code assay may serve as an alternative to PCR, it may have its most 
significant impact in protein marker-based diagnostics as it is up to 106 times more 
sensitive than ELISA-based technology.20 
 Again, the major drawback of this application is the possibility for high 
background signal and the report of false positives due to the use of antibodies as the 
primary detector.   
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Antibody-Liposome-PCR 
 This methodology uses liposomes with encapsulated DNA reporters and 
ganglioside receptors (non-specific) embedded in the bilayer as a detection agent.  The 
first step of this reaction is similar to ELISA: the target is immobilized by a capture 
specific antibody.  After a blocking step, the liposomal detection reagent is added and 
allowed to incubate for one hour.  After rinsing the plate with phosphate buffered saline 
(PBS), adding DNase I to degrade unencapsulated DNA, and inactivating it by heat, the 
liposomes are ruptured with Triton X-100 and the encapsulated reporters are released.  
The samples are then quantified by real-time PCR with comparison to a standard linear 
curve.21 
 One of the disadvantages of this approach is that the liposomes with encapsulated 
reporter sequences do not have a stable shelf-life – the reporter sequences can actually be 
released from the liposomes over time.  Another disadvantage is the possibility for false 
positives if unencapsulated DNA is not removed completely or if non-specific binding 
occurs either at the capture antibody or at the non-specific ganglioside level.  High 
background signal can also occur at low concentrations of target due to non-specific 
binding. 
 
Proximity Ligation Assay 
 In this technique, the spatial convergence of sets of protein-binding reagents on 
target molecules brings nucleic acid sequences closer together.  After the strands of DNA 
have been ligated, a DNA reporter sequence is created which can then be amplified.  This 
procedure translates proteins of interest to specific nucleic acid sequences.  In general, 
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sets of target-specific probes are made; these can be antibodies or nucleic acids that have 
been screened for increased affinity to the target.  Each probe has a DNA extension.  
Once the probes have bound their target, the DNA extensions are brought in proximity to 
each other. A connector oligonucleotide, added in molar excess, hybridizes to the DNA 
extensions and guides enzymatic DNA ligation.  The ligated DNA sequence is then 
amplified using real-time PCR and detected.  If a probe fails to bind a target molecule, 
the DNA extensions are not brought together and ligation will not occur.22-24 
 Since this technique relies on antibody or nucleic-acid-based detection, both 
specificity and sensitivity may be compromised.  This problem can especially occur at 
low concentrations of target. 
 
Filament-Antibody Assay 
 This approach is based on circumferential bands of antibodies coupled to a 120 
µm diameter polyester filament.  Automated processing is achieved through sequential 
positioning of filament-coupled probes through a series of 25 - 60 µl liquid filled 
microcapillary chambers.  Filament motion first positions the antibodies within a 
microcapillary tube containing a solution of virus before moving the probes through 
subsequent chambers, where they are washed, exposed to fluorescently labeled antibody, 
and washed again.  A flatbed microarray scanner is used to measure filament 
fluorescence; an increase in fluorescence can be seen in regions containing antibody-
coupled probes.  While this design may be useful in point-of-care settings and for the 
detection of biohazardous materials, its greatest advantage is that it is a tool for 
automated molecular recognition.25 
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 One drawback of this method is the reliance on antibody-based detection, which 
can lead to false positives, especially with low pathogen concentrations.  Also, in its 
current form, an amplification step is not included, which limits the sensitivity of this 
technique.  
 
Nanoscale Detection Assays 
 A variety of nanoscale applications have been recently introduced with the goal of 
being rapid, sensitive, specific, and economical.  For example, atomic force microscopy 
coupled with an initial immuno-capture step has been used for the direct visualization of 
viruses by measuring deflections caused by forces or interactions between the tip and 
surface of the sample.  These deflections are measured by a laser beam reflected off a 
spot on the cantilever at a photodiode detector.26, 27  Semiconducting nanowires coated 
with antibodies and configured as field-effect transistors can also be used.  When they 
bind to a charged macromolecule, a change in conductance across the circuit, 
proportional to the amount of bound target, is detected.27, 28  Magnetic nanoparticles have 
also been utilized for their ability to create viral-induced nanoassemblies or agglomerates 
of viral particles bound by magnetic nanoparticles which can then be visualized by light-
scattering experiments.27, 29  Finally, quantum dots or fluorescent nanoparticles are also 
being used by looking at two colors that are functionalized with antibodies, spectrally 
separated, and analyzed for coincidence in real time.30  One method uses quantum dots 
conjugated to antibodies to monitor the progression of respiratory syncytial virus 
(RSV).31 
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The majority of these methods are still quite expensive and, as they are all 
antibody-based, the possibility of false positives and high background signal remains.  
Some of them also require complex instrumentation and specialized skills.  Finally, these 
methods are still in the proof-of-concept stage, meaning there is a large amount of 
optimization needed before they can be used on a wide-scale basis. 
 
DNA and Molecular Computing 
 As Figure 2 shows, part of our detection method is based on performing logical 
operations among DNA sequences.  For nearly fifteen years, various attempts have been 
made to manipulate DNA to use it as inputs and outputs of computational operations.  
The title "DNA computing" is applied to experiments in which DNA molecules have 
computational roles.  Sequences, often about 8-20 base pairs, are used to represent bits 
and a variety of methods have been devised to manipulate and evaluate them.  Certain 
properties of DNA make it an excellent choice for computational processes – it is both 
self-complementary (single-stranded DNA selects its own Watson-Crick complement) 
and it can easily be copied.  Also, there is a vast molecular biology toolbox already in 
place for manipulating DNA, including restriction enzyme digestion, ligation, 
sequencing, amplification, and fluorescent labeling.32  Similarly, we propose to use DNA 
logic tags as inputs to logical operations in our application. 
 
Adleman's Solution to the Traveling Salesman Problem 
 In his paper in Science in 1994, Adleman solved a simplified version of a famous 
NP-complete computer problem called the Traveling Salesman Problem.33  NP-complete 
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problems are a class of search problems for which the correctness of the solution is easy 
to check.  They are also the hardest of problems because they require exponentially 
increasing amounts of time to solve.32 
 His problem asks whether, given a set of n cities ('vertices') with m paths ('edges') 
connecting them, a Hamiltonian path exists that starts at a given vertex vin, passes through 
each vertex exactly once, and ends at vertex vout.  An average computer available today 
can easily solve this problem for small values of n.  However, if n becomes very large, 
the amount of time required to generate and check every possible solution increases 
exponentially, making large calculations very infeasible.33 
 Adleman used a simple, brute-force algorithm which generated random paths 
through the graphs, discarded any path that did not begin at vin and end at vout, discarded 
any that did not enter exactly n vertices, and discarded any that did not pass through each 
vertex at least once.  He accomplished this by synthesizing a random 20 base pair DNA 
oligonucleotide to represent each vertex, followed by another series of 20-mers to 
represent edges.33  DNA that represented the edge had a certain built-in feature: the first 
ten nucleotides complemented the last ten bases of one vertex, and the last ten 
complemented the first ten bases of another vertex.  When the mixture of DNA is 
denatured at high temperatures and then cooled, an oligonucleotide representing an edge 
will anneal to form a splint to connect both vertices and DNA ligase can join together all 
possible combinations.  The bulk-annealing step allows this molecular approach to test a 
massive number of possibilities in parallel.32 
 After the first step of denaturing, hybridizing, and ligating, over 1013 strands of 
DNA were generated.  Adleman assumed that at least one encoded the Hamiltonian path.  
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In order to check for this, he used a series of well-developed molecular biology 
techniques.  First, all sequences that began at vin and ended at vout were selectively 
amplified by PCR using primers specific to those sequences.  Any path that did not pass 
through exactly seven points was eliminated by gel-purifying only the 140-base pair 
product (equal to seven 20-mers).  To remove solutions that did not pass through each 
vertex exactly once, the product from the gel purification was affinity purified by a 
single-stranded 20-mer complementary to the sequences of the second vertex.  This step 
was performed for each vertex except the first and last since those were already bound by 
vin and vout PCR primers.33 
 Any remaining product indicated that a Hamiltonian path did exist.  In order to 
confirm this, graduated PCR was done on the final product, which involved a series of six 
different PCRs, using the vin forward primer and a primer complementary to each of the 
other 20-mer vertices, which were then analyzed in separate lanes on a gel.  Adleman's 
path had a readout showing bands of 40, 60, 80, 100, 120, and 140 base pairs.32 
 Comparing this first experimental demonstration of DNA computing to computers 
of its time, Adleman stated that a typical computer can execute about 106 operations per 
second and the fastest supercomputer can execute about 1012.33  Although the entire 
process took about seven days of laboratory work, if each ligation step counts as an 
operation, Adleman's molecular computer did over 1014.  If the ligation step was scaled 
up, over 1020 operations per second could be performed.  Also, an extremely small 
quantity of energy – 2 x 1019 ligations (operations) per joule – was consumed, with 
modern computers operating at 109 operations per joule.  Finally, one bit of information 
can be stored in a cubic nanometer of DNA, which is about 1012 times more efficient than 
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existing storage media, meaning that DNA computers have the potential to be faster and 
more efficient than any electronics developed so far.32, 33  
 At this time, however, DNA computing is still in its infancy.  Practical 
applications have not yet been developed to use on a wide-scale basis.  
 
DNA Nanomachines 
 Closely related to the performance of logical or computing operations among 
DNA is the use of DNA to build other structures.  Recently, the manipulation of DNA 
has been extended to DNA nanomachines where DNA is used to build synthetic 
molecular machinery.  It was inspired by biological systems where individual molecules 
act alone and together as specialized machines.  This new technology aims to take 
advantage of systems already in place within biology.  DNA nanomachines are made by 
self-assembly, using techniques that rely on sequence-specific interactions that bind 
complementary oligonucleotides together in a double helix.  These nanomachines can be 
activated by interactions with specific signaling molecules or by changes in their 
environment and can be used for molecular sensing, intelligent drug delivery, or 
programmable chemical synthesis.34  Our detection strategy also calls for the use of 
changes in environment (heat) to create interactions between specific DNA logic tags, 
enabling their cleavage and the execution of a NOT operation. 
 
Boolean Control and Logic Gates 
 In 2005, Stojanovic, et al., reported a solution-phase molecular-scale computation 
media with "Lego-like" deoxyribozyme-based logic gates.  Their approach combined the 
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concept of molecular logic gates with DNA computation and allowed for the bottom-up 
building of computational complexity in solution.  This new application was 
demonstrated by the synthesis of molecular automata and by the engineering of molecular 
circuits.  They also produced a series of molecules that performed Boolean calculations, 
allowing for analysis of a series of inputs and a decision process to produce or not 
produce an output.  Output production is based on the presence or absence of inputs and 
the particular formula they encode.  They were also able to use the logic gates to control 
the functional state of small pieces of oligonucleotides, switching them on or off based on 
the outcome of previous computations.35, 36 
 
Nucleic Acid Logic Circuits 
 In order to systematically create complex yet reliable circuits, electrical engineers 
use digital logic, where gates and subcircuits are composed modularly and signal 
restorations prevent signal degradation.  Biological organisms perform complex 
information processing as well, but engineering synthetic circuits has remained 
ineffective compared with that of electronic circuits.  In 2006, Seelig, et al., reported the 
design and experimental implementation of DNA-based digital logic circuits, including 
AND, OR, and NOT gates, signal restoration, amplification, feedback, and cascading.  
Using single-stranded nucleic acids as inputs and outputs, the mechanism relies solely on 
sequence recognition and strand displacement.37 
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DNA Logic Tag Computing 
Our application describes a new paradigm in DNA log tag antibody-based 
detection and a practical application of DNA computing embodied within a molecular 
sensor design.  In the proposed approach, DNA logic tags are purposely designed to 
facilitate logical operations among tags, which are associated to different antibodies.  As 
described in the next chapter, we hypothesize that this approach permits binary NOT 
operations to control for non-specific antibody interactions among two tags to increase 
detection specificity without sacrificing sensitivity. 
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CHAPTER II 
 
VIRUS DETECTION WITH DNA LOGIC TAGS 
 
Abstract 
 Non-specific antibody binding limits the sensitivity of antibody-based detection 
technologies.  We explore the use of logical operations among DNA logic tags associated 
with antibodies in order to increase specificity and sensitivity.  DNA sequences were 
developed to perform a logical NOT operation with the goal of subtracting non-specific 
binding prior to PCR amplification.  Antibody-associated tags A and A' are designed to 
be partially complementary and contain a restriction enzyme site.  Tag A is associated 
with a specific antibody; tag A' is associated with an isotype matched control antibody.  
If the concentration of A is greater than A', hybridized AA' is enzymatically cleaved and 
remaining tag A is subsequently amplified during real-time PCR.  Quartz crystal 
microbalance (QCM), DNA agarose gels, and PCR were used to experimentally 
characterize components of the NOT operation in respiratory syncytial virus (RSV) 
detection.  QCM showed gold nanoparticles functionalized with both tag DNA and 
antibody bound virus.  Successful enzymatic cleavage of AA' was visualized on a DNA 
agarose gel.  After cleavage, remaining tag A was amplified by the addition of primers 
and standard real-time PCR.  In the presence of RSV, magnetic pulldown led to the 
delivery of both tag A and A'.  When PCR was run after enzymatic cleavage, the PCR 
cycle threshold value was increased.  Our results suggest that combining the careful 
design of DNA logic tags, their association with antibodies, and standard molecular 
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biology techniques is a promising approach to increase the specificity and sensitivity of 
antibody-based detection methods. 
 
Introduction 
 An increasing number of molecular biomarkers are used in diagnostic procedures 
for a wide variety of diseases like influenza, SARS, pneumonia, cancer, and even heart 
disease.  The need for rapid methods to detect low concentrations of biomarkers is 
becoming more critical.  However, current methods of detection often fail when a 
biomarker is present at low concentrations, potentially leading to situations where a 
biomarker is not detected (false negative) or a biomarker is incorrectly identified as being 
present (false positive).  Building detection platforms that provide sensitive, reliable, 
rapid, and quantitative identification of biomarkers would improve the prospects for 
earlier detection and the timely implementation of the correct course of treatment. 
In many detection applications, antibodies are used as the initial detector interface 
due to their plasticity and very high specificity.  Enzyme-linked immunosorbent assays 
(ELISA) are the gold standard of antibody-based detection technologies.1  More sensitive 
methods, like immuno-polymerase chain reactions (IPCR) and antibody-nanoparticle-
DNA reporter tag assays have also been developed.2, 3  However, a drawback of highly 
sensitive antibody-based detection technologies is the innate presence of non-specific 
interactions between antibodies and undesired targets, leading to false positives.   
The detection platform described in this thesis combines two aspects of previous 
work, DNA reporter tags and DNA computing, to control for non-specific antibody-
antigen interactions by performing a Boolean NOT operation using nanoparticle surface 
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structures, which we call DNA logic tags.  The basic idea of this approach is illustrated in 
Figure 1 and Figure 2, which describe the two steps: formation of an ELISA-like 
antibody-antigen complex (Figure 1) and the implementation of a logical NOT operation 
(Figure 2). 
As shown in Figure 1, a unique DNA logic tag sequence, e.g. A (red line in the 
upper left), is hybridized to DNA bound to gold nanoparticles.  DNA logic tag A is 
associated with a specific antibody (red branched structure) since they are both 
conjugated to a gold nanoparticle.  Combining this with an antibody-magnetic bead 
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Figure 1. Basic components of the DNA logic tag delivery system.  Three components 
are added to a solution containing antigen: magnetic beads coupled to polyclonal 
antibody (top center), gold nanoparticles coupled to specific monoclonal antibody and 
DNA logic tag A (red; top left), and gold nanoparticle coupled to non-specific antibody 
and logic tag A' (green; bottom left). The presence of antigen in solution results in the 
magnetic pulldown of the ELISA-like sandwich shown on the right.  This complex 
contains DNA logic tag A associated with specific target antibody and its complement 
A' associated with non-specific antibody. 
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construct, antibody binding to target results in an ELISA-like sandwich and delivery of 
the DNA tag to an analyte solution.  In addition to the gold nanoparticles conjugated to 
specific antibody and its unique DNA logic tag A (red), a second gold nanoparticle is 
added to the antigen test solution, which is coupled to a matched non-specific antibody 
and DNA logic tag A' (green).  Although the second antibody is not specific to the target, 
it may become entrapped non-specifically in the magnetic pulldown complex; this 
entrapment mirrors any non-specific entrapment of the specific antibody in the magnetic 
pulldown complex.  Sequence A and A' are designed to enable logical operations among 
tags.  In this approach, they can be used to perform tag subtraction to remove non-
specific antibody interactions. 
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Figure 2 describes how the NOT operation is used to subtract non-specific 
binding events prior to amplification by PCR.  DNA logic tag A is designed with a 
restriction enzyme site and tag A' contains the complementary site.  After being released 
from gold nanoparticles, the tags' complementary regions hybridize.  A restriction 
enzyme is then used to cleave hybridized A-A'.  Figure 2 illustrates the case when tag A 
is delivered in excess of tag A', which should occur if antibody targets are present in the 
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Figure 2. The NOT operation is used to decrease effects of non-specific binding.  DNA 
logic tags are recovered from the sandwich ELISA-like complex by heating.  DNA logic 
tag A contains a restriction enzyme cleavage site.  Non-specific antibody interactions 
deliver complement A’.  In the illustration, the presence of antigen results in an excess of 
tag A compared to tag A'.  The hybridized double-stranded DNA (AA') is cleaved by a 
restriction enzyme.  Intact tag A remaining in solution is subsequently amplified and 
detected by real-time PCR. 
 27
analyte solution.  Restriction enzyme digestion reduces the number of copies of A, but 
remaining A is amplified by PCR to indicate the presence of target.  If the two antibodies 
are matched with respect to their non-specific binding characteristics, then the reduction 
in the number of copies of tag A should account for non-specific binding from the 
specific antibody.  This will serve to reduce the likelihood of generating a false positive 
due to non-specific binding. 
 
Materials and Methods 
 
DNA Logic Tag Design 
Carefully designed DNA structures are critical for the success of this approach.  
Three criteria were used to design DNA logic tags.  First, each oligonucleotide had at 
least 60 base pairs to make PCR a more reproducible process (since DNA polymerase has 
an optimal range for amplification) and at most 120 base pairs to allow commercial DNA 
synthesis.  Secondly, the oligonucleotide was designed with a TaqMan® probe site to 
provide a more specific alternative to intercalating dyes like SYBR Green.  Finally, the 
logic tag sequence was made to contain a blunt-end restriction enzyme cleavage site close 
to the 3' end.  This placement has the largest effect on PCR because DNA replication 
stops before incorporation of TaqMan probes (Figure 3). 
 In order to achieve these criteria, initial sequences were generated using two 
different approaches.  First, pieces from the mouse genome found in literature were used 
as inputs to the applications listed below.38  Second, sequences from the other parts of the 
mouse genome were scrambled using an internet-based word scrambler program 
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(http://www.lerfjhax.com/scrambler) and checked using BLAST to make sure they had 
little to no similarity with the human genome to decrease the possibility of contamination.  
Due to the uncertainties associated with the amplification of synthetic DNA, sequences 
generated both from nature and randomness were input into RealTimeDesign (Biosearch 
Technologies, Novato, CA) and SciTools Primer Quest (Integrated DNA Technologies, 
Coralville, IA).  In both applications, the TaqMan design model was selected and the 
initial parameters were set so that the length of the output sequence was between 60 and 
120 base pairs.  The cleavage site criterion was determined by inputting the 
oligonucleotide into NEBcutter V2.0 (New England Biolabs, Beverly, MA) to find any 
blunt-end restriction enzyme site that was 20 to 40 base pairs from the 3' end to avoid the 
PCR primer site.  A restriction enzyme was selected if it reacted with unmethylated DNA 
strands and if it could be inactivated.  Also, it had to have little to no star activity (relaxed 
or altered specificity) and it should not cleave single-stranded DNA. 
If an amplicon, its corresponding primers and TaqMan probe were generated by 
both programs, it was then selected as a candidate DNA logic tag.  The top five assays 
were selected from both the mouse genome and the word scrambler methods of 
generating DNA sequences.  Ten DNA logic tag candidates in total were chosen, tested, 
and optimized (see below).  They were tested against each other to see how quickly they 
began to amplify and how few copies could amplify consistently.  Each candidate's 
length was also verified by running the PCR product on an agarose gel (see below).  
Eight of the ten initial candidates performed well, but most did not consistently amplify 
lower copy numbers. 
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From these evaluations, T7-76, a result of the word scrambler method (Figure 3, 
Table 1), was selected as the best choice to use in subsequent tests.  The candidates were 
labeled sequentially followed by their length, i.e. T7-76 was the seventh candidate tag 
and it was 76 base pairs long.  Every sequence related to T7 began with T7, an 
abbreviated description (LP = left primer, RP = right primer, comp = complementary 
strand, RC = restriction complement, TaqMan = TaqMan probe), and its length.  
T7comp-55 was 40 bases long: an exact complement to the 3' end of T7-76 with a thiol-
C6-linker and 15 thymines (Ts) on the 5' end.  Fifteen Ts were used as a spacer since they 
have been shown by others to have the lowest surface interaction with gold to maximize 
surface coverage and stability.39 
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Figure 3. Schematic of T7-76.  This DNA logic tag is 76 bases long and contains sites for 
primer and TaqMan probe attachment, as well as for specific restriction enzyme cleavage.  
The white spaces are regions of DNA that do not have a specific purpose besides adding to 
the length 
 
Restriction Complement Design  
 To implement the NOT operation, a second sequence closely related to the logic 
tag was required.  This oligonucleotide was complementary to the region surrounding the 
restriction enzyme site of the DNA logic tag and was random in other regions where 
logic tag primers could potentially bind.  After evaluating the sequence T7-76 with 
NEBcutter, we found that it had a blunt-end restriction enzyme site for enzyme HpyCh4V 
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at 44 bases.  Accordingly, we designed T7_RC-76 with a 20 base pair region 
complementary to the restriction digest site; the other 56 bases were generated from the 
word scrambler program listed above (Table 1).  Similar to the complement to T7-76, 
T7_RCcomp-55 was designed as the exact complement to 40 base pairs of T7_RC-76 
with a thiol-C6-linker and 15 Ts. 
 
Table 1. Sequence designs for DNA logic tags 7, 8, and 12.  Also shown are the related 
primers, TaqMan probes, restriction complement (for T7-76 only) and coupling sequences (for 
T7-76 only). 
 
Sequence Name Sequence (5' to 3') 
T7-76 CTGCGACGATCTACCATCGACGTACCAGGTCGGTTGAAGGA
CCGTGCATAGCGAAATCTCAACTTACGAGACAAGC 
T7-LP-17 CTGCGACGATCTACCAT 
T7-RP-18 GCTTGTCTCGTAAGTTGA 
T7-TaqMan CALFluor® Gold 540CGTACCAGGTCGGTTGAAGGACCBHQ-1 
T7comp-55 Thiol-C6-linker-TTTTTTTTTTTTTTTGCTTGTCTCGTAAGTTGAG 
ATTTCGCTATGCACGGTCCTT 
T7_RC-76 TTACGTGGAGTACGCTTTGATTTCGCTATGCACGGTCCCGCA
TTTGAGGCCAGTTAGACGGCCAGTTGACCGTACT 
T7_RCcomp-55 Thiol-C6-linker-TTTTTTTTTTTTTTTAGTACGGTCAACTGGCCG 
TCTAACTGGCCTCAAATGCGGG 
T8-87 AACGGGAAGCCCATCACCATCTTCCAGGAGCGAGACCCCAC
TAACATCAAATGGGGTGAGGCCGGTGCTGAGTATGTCGTGG
AGTCT 
T8-LP-16 AACGGGAAGCCCATCA 
T8-RP-18 AGACTCCACGACATACTC 
T8-TaqMan CAL Fluor® Gold 540CCATCTTCCAGGAGCGAGACCCBHQ-1 
T12-96 GGAGAACCCTGGACATTCCAACCCTTCACCTTGGCGAGTCCC
TAATCCTCGGCTAACGCAAGGCCAAACCACAATCCTCTTTGG
TTGAGTTCCTCG 
T12-LP-16 GGAGAACCCTGGACAT 
T12-RP-18 CGAGGAACTCAACCAAAG 
T12-TaqMan CAL Fluor® Gold 540CCAACCCTTCACCTTGGCGAGTBHQ-1 
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Real-Time Polymerase Chain Reaction (PCR): Protocol and Optimization 
Real-time PCR was performed using a SmartCycler II thermal cycler system 
(Cepheid, Sunnyvale, CA).  Reactions were done in a 25 µL volume with 12.5 µL of iTaq 
SYBR Green Supermix with ROX (0.4 mM dATP, 0.4 mM dCTP, 0.4 mM dGTP, 0.8 
mM dUTP, iTaq DNA polymerase, 50 units/ml, 6 mM Mg+2, SYBR Green I dye, 1 µM 
ROX reference dye, and stabilizers, product number 170-8851, Bio-Rad Laboratories, 
Hercules, CA), 200 nM left and right primers, and nuclease-free water.  The best protocol 
was a three-step PCR, beginning with an initial iTaq DNA polymerase activation step of 
95°C for 3 minutes followed by 40 cycles of 95°C for 30 s to denature, 56°C for 30 s to 
anneal and extend, and 78°C for 6 s to detect fluorescence (see below). 
To determine the optimal concentration of primers and MgCl2 as well as the 
temperature settings and cycle conditions, a variety of optimization steps were 
completed.14  The first parameter explored was the concentration of MgCl2.  Since iTaq 
SYBR Green supermix already contains 6 mM Mg+2, additional MgCl2 was added in 
increments of 25 nmol to bring the final concentration in the PCR mix to 400 nM, 500 
nM, 600 nM, 700 nM and 800 nM.  For optimization of primer concentration, a similar 
approach was taken: a range of primer concentrations was tested.  First, both the left and 
right primers were increased in parallel from 100 nM to 500 nM in 100 nM increments.  
Next, the concentration of one primer was kept constant while the other one varied from 
100 nM to 500 nM in 100 nM increments.  Finally, the temperature settings were 
determined by examining the times and temperatures of the annealing and extension steps 
and the temperature of the read step.  The times tested were 15s, 30s, 45s and 60s for the 
annealing and extension steps.  The temperatures of the annealing step were between 
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52°C and 64°C, incremented by 2°C.  For the extension step, temperatures between 60°C 
and 78°C were tested in increments of 2°C.  These results were compared to those from 
testing combined annealing and extension steps at temperatures between 52°C and 62°C.  
We were able to take advantage of the Cepheid thermocycler's flexibility and run various 
reactions in parallel with different temperatures and times for each step in the PCR 
cycling process. 
The optimal parameters for running PCR were determined by evaluating the cycle 
threshold (Ct) values or the point at which PCR product began to amplify(or pass a 
certain fluorescence value.  Another criteria used to identify the best protocol was if the 
temperature cycling formed primer dimers; this was determined by melting curve 
analysis where the product generated by PCR was cooled to 45°C and heated 0.2°C/sec 
up to 95°C using the thermocycler's melt curve program.  The fluorescence was read 
during the entire process.  Primer dimer formation was also verified by agarose gel 
electrophoresis.  Once the optimized protocol and concentrations were determined, they 
were repeated for verification and used in subsequent reactions. 
 
Decreasing Crossover Contamination 
Due to the use of high concentrations of DNA logic tags within our experiments, 
from PCR, coupling reactions, and restriction digests, steps were taken to minimize the 
potential for cross-contamination.  First, reagents like nuclease free water and primers 
were aliquotted and new aliquots were typically used daily.  Secondly, aerosol barrier tips 
were always used to decrease accumulation of template within pipettes.  Finally, using 
AmpErase (N808-0096, Applied Biosystems, Foster City, CA) degrades product with 
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uracil from previous PCR amplifications.  Instead of incorporating thymine into our PCR 
product, the nucleotide mix in the iTaq SYBR Green supermix contained uracil.  This 
provided the option of using AmpErase if PCR product contamination from previous 
reactions was suspected; in such cases, a preliminary step was added to our standard PCR 
process of 50°C for 3 minutes before the protocol described above. 
 
Agarose Gel Electrophoresis 
To verify the results from PCR and restriction enzyme digestion, agarose gels 
were run.  10 µL of samples were mixed with 1 µL 10X SYBR Gold (S-11494, 
Molecular Probes, Eugene, OR) in dimethylsulfoxide (DMSO), and 0.5 µL 10X loading 
buffer (170-8351, Bio-Rad Laboratories, Hercules, CA).  The samples and 5 µL of EZ 
load 20 base pair molecular ruler (170-8351, Bio-Rad Laboratories, Hercules, CA) 
combined with 1 µL SYBR Gold were run on a 4% MetaPhor agarose gel (50180, 
Cambrex Bio Science Rockland, Inc., Rockland, ME) with Tris-Borate-EDTA for 30 
minutes to 1 hour at 120 V.  The gels were then visualized under 254 nm ultraviolet light 
using the BioDoc-It Gel Documentation System (UVP, Inc., Upland, CA). 
 
Restriction Enzyme Experiment 
To test the NOT operation, T7-76 hybridized with T7_RC-76 were cleaved by the 
HpyCH4V restriction enzyme which cuts the complementary strands of TG↓CA (5' to 3') 
and its palindrome AC↓GT (3' to 5').  The reaction was prepared by adding 5 units of 
HpyCH4V to 88 ng T7-76 and 200 ng T7_RC-76 (corresponding to 5.2x1011 and 
1.5x1012 copies respectively) in incubation buffer (50 mM potassium acetate, 20 mM 
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Tris-acetate, 10 mM magnesium acetate, 1 mM dithiothreitol, at pH 7.9) from New 
England Biolabs (R0620S, Beverly, MA).  This mixture was then incubated at 37°C for 1 
hour, followed by a heat inactivation step of 72°C for 25 minutes.  In order to verify the 
results, the samples were then examined using agarose gel electrophoresis and/or PCR. 
 
Coupling of Antibodies to Magnetic Microparticles 
MagnaBind™ amine derivatized 1 μm magnetic microparticles (MMPs, product 
number 21352, Pierce Biotechnology, Rockford, IL) were activated with succinimidyl 4-
[N-maleimidomethyl]cyclohexane-1-carboxylate (SMCC).  In a typical reaction, 23 μL of 
10 nM SMCC in DMSO were added to 200 μL of MMPs.  The solution was mixed and 
allowed to sit at room temperature for one hour.  The MMPs were then cleaned by 
placing an external magnetic field perpendicular to gravity next to the solution.  After one 
minute, the solution became clear and MMPs were pulled to the side of the tube.  When 
the clear supernatant and the external magnetic field were removed, the MMPs were 
resuspended in phosphate buffered saline (PBS) at pH 7.4.  The washing process was 
repeated three times. 
Antibody reduction was coordinated so that once the MMPs were activated, they 
could be immediately used.  Dithiothreitol (DTT) was used to reduce F-mix antibodies, 
which is an equal mixture of two anti-respiratory syncytial virus (RSV) fusion protein 
antibodies (clones 1269 and 1214).  6.1 μL of 1 M DTT was added to 300 μL of purified 
antibodies at 1 mg/mL concentration in PBS.  The solution was mixed and allowed to sit 
at room temperature for 0.5 hours.  After that time, the antibodies were separated from 
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DTT using a NAP-5 column (17-0853-01, GE Healthcare Bio-Sciences Corp., 
Piscataway, NJ). 
The activated MMPs were combined with the column-purified reduced antibodies 
and allowed to react for one hour at room temperature.  The conjugation was quenched 
by the addition of β-mercaptoethanol to a final concentration of 100 μM.  The remaining 
solution was purified by placing an external magnetic field perpendicular to gravity next 
to it.  After one minute, the solution became clear and the conjugated MMPs were pulled 
to the side of the tube.  Both the clear supernatant and the external magnetic field were 
removed; the remaining conjugated MMPs were resuspended in 500 μL PBS.  The 
washing process was repeated three times. 
 
Coupling of Antibodies and DNA to Gold Nanoparticles 
 Thiolated DNA sequences (T7comp-55, Table 1, Biosearch Technologies, 
Novato, CA) were received as disulfides and were activated by cleaving the disulfide 
bond.  Cleavage was performed in 100 mM DTT, 0.1 M phosphate buffer, pH 8.3.  After 
0.5 hours, thiolated DNA was desalted using Microcon YM-3 centrifugal filters (4410, 
Millipore, Billerica, MA).  The purified DNA was diluted to 30 μM in water and stored 
in small aliquots at -80°C. 
In a typical reaction, 3.5 μL of 0.2 mg/mL Synagis® antibody (humanized 
monoclonal antibody known to target the A antigenic site of RSV's fusion protein, 
product number NDC 60574-4114-1, MedImmune, Inc., Gaithersburg, MD) were added 
to 1 mL of 2.325 nM, 15 nm diameter gold nanoparticles (AuNPs, product number 
15704-1, Ted Pella, Redding, CA) at pH 9.3 and placed on a rotator for 30 minutes.  
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After 30 minutes, 20 μL of activated DNA was added; the AuNPs were then rotated for 
another 30 minutes.  The solution was brought to 0.1 M NaCl, 10 mM phosphate buffer, 
and 0.02% Tween20 and allowed to sit for one hour.  After this time, the concentration of 
NaCl was brought to 0.2 M and to 0.3 M after a third hour.  Excess DNA was removed 
by centrifuging the solution for 30 minutes at 13,200 rpm.  The clear supernatant was 
then removed and the red oily pellet was resuspended in a stock solution of 0.2 M NaCl, 
10 mM phosphate buffer, and 0.02% Tween20.  This washing process was repeated three 
times.  After washing, particles were resuspended in a stock solution containing DNA 
logic tags (T7-76, Table 1) and allowed to sit at room temperature overnight.  Finally, 
excess DNA was removed using the washing method described above. 
 
Preparation of RSV stock 
RSV stock was prepared by infecting a confluent T-150 flask of HEp-2 cells with 
RSV.  Infection was allowed to proceed for 4 days, after which cells were scraped from 
the surface of the T-150 flask.  The supernatant containing the cells was collected in a 50 
mL centrifuge tube.  The supernatant was then frozen using a slurry of ethanol and dry 
ice.  After freezing, the supernatant was thawed in a 37°C water bath.  The 
freezing/thawing cycle was repeated three times to ensure the release of virus particles 
from the cell wall.  After the third cycle, the supernatant was separated into aliquots of 1 
mL and stored at -80°C.   
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Titer of Virus Stock 
 Once the virus stock was prepared, 1 mL aliquots were used to infect 3 columns 
of a 24-well microtiter plate.  After infection, the cells were incubated for 1 hour at 37°C 
and 5% CO2.  The cells were then overlaid with 1 mL of media containing 
methylcellulose and incubated for 4 days at 37°C and 5% CO2.  After incubation, the 
cells were fixed with cold 80% methanol and stored at 4°C for at least one hour.  Cells 
were blocked with 2% BSA in Dulbeccos’ PBS (Mg2+ and Ca2+ free) for 1 hour.  After 
blocking, the cells were incubated for 30 minutes at room temperature with a 1:1000 
dilution of F-mix antibody (final concentration of 20 μg/mL).  The cells were then 
washed with PBS and incubated in a 1:1000 dilution of secondary antibody (goat anti-
mouse HRP, product number SC-2005, Santa Cruz Biotechnology) for 1 hour.  Excess 
antibody was removed with PBS.  The HRP was then developed with a substrate which 
rendered a colored dot.  The dots were then counted to quantify the amount of plaque 
forming units (PFU) in the aliquots, giving a titer of 4.0x105 PFU/mL. 
 
Magnetic Microparticle Pulldown Experiment 
Pulldown experiments were performed to validate the attachment of antibodies to 
magnetic microparticles (MMPs).  Ten µL of antibody-conjugated MMPs and 100 µL of 
a stock solution of RSV (1.675x106 PFU/mL) in 2% bovine serum albumin (BSA) were 
used.  MMPs and virus were mixed and placed on a rotator for two hours.  Unbound virus 
was then removed from the MMPs by cleaning as previously described in the antibody-
MMP coupling reaction; this was done three times.  Next, the MMPs were mixed with 
100 μL of 12 μg/mL F-mix antibody with a 655 nm quantum dot attached to the antibody.  
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The solution was stirred and placed on a rotator for two hours; unbound quantum dot-
coupled antibodies were removed by cleaning the beads three times.  After cleaning, the 
MMP-RSV-quantum dot complexes were placed in a 96-well plate on a BioMag® 96-
well Plate Side Pull Magnetic Separator (85072, Polysciences, Inc., Warrington, PA) and 
imaged on a Zeiss Axiovert 200 inverted fluorescence microscope. 
 
Fluorimetric Validation of DNA-Gold Nanoparticle Attachment 
 Activated DNA was attached to gold nanoparticles following the procedure stated 
above.  After removal of excess activated DNA, complementary DNA with a conjugated 
fluorescein isothiocyanate (FITC) dye (Operon Biotechnologies, Inc., Huntsville, AL) 
was added to the AuNPs.  As a control, FITC-DNA was also added to PBS without 
AuNPs.  The amount of complementary DNA added to 100 μL of AuNPs or phosphate 
buffer was varied to determine the optimal molar ratio of DNA:AuNPs for hybridization.  
After sitting at room temperature for 24 hours, the solution was centrifuged for 30 
minutes at 13,200 rpm to pellet the AuNPs and any DNA conjugated to them.  
Fluorescence of the supernatant was obtained on a Bio-Tek Synergy HT plate reading 
fluorimeter. 
 
Quartz Crystal Microbalance Validation of Antibody-Gold Nanoparticle Attachment 
All quartz crystal microbalance (QCM) experiments were performed on a 
Maxtek, Inc. Research Quartz Crystal Microbalance with a flow rate of 30 μL/min.  The 
crystals used were 5 MHz Ti/Au quartz crystals.  After equilibrating for 30 minutes in 
PBS, a 5 minute PBS baseline was obtained.  A RSV stock solution containing 4.0x105 
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PFU/mL was then allowed to flow over the crystal for 10 minutes, followed by an 
additional five minutes of PBS.  After RSV binding, non-specific binding was blocked by 
letting a 1% BSA solution flow over the crystal for ten minutes followed by ten minutes 
of PBS.  At this point, the flow was switched to AuNPs functionalized with anti-RSV 
antibodies and DNA and, as a control, AuNPs functionalized with DNA alone. 
 
Respiratory Syncytial Virus Pulldown with Magnetic Microparticles and Gold 
Nanoparticles 
 
 Pulldown experiments used 5 µL of antibody-conjugated MMPs, 100 μL of a 
stock solution of RSV (4.0x105 PFU/mL) or 100 μL of HEp-2 cell lysate as a negative 
control and 200 μL of 5% bovine serum albumin (BSA).  The MMPs, virus, and BSA 
solution were mixed and placed on a rotator for one hour.  Unbound virus was then 
removed from the MMPs by cleaning as previously described.  After being cleaned three 
times, the MMPs were mixed with 1 μL of 2 nM antibody-DNA functionalized AuNPs 
and 300 μL of 5% BSA and placed back on the rotator for one hour.  The MMPs were 
then washed two times in 5% BSA followed by three additional washes in PBS.  After 
the final wash, MMPs were resuspended in 200 μL of DNase-free water.  Solutions were 
then held at 90°C for ten minutes followed by placement in an external magnetic field 
and removal of 150 μL of supernatant.  The supernatant was then used in PCR and 
restriction cleavage reactions. 
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Results 
C D
 
Figure 4. Images of antibody-virus complexes after magnetic pulldown experiments in 
RSV.  A mixture of MMPs unconjugated (left panels) or conjugated (right panels) to F-
mix antibodies and 655 nm quantum dots conjugated to F-mix antibodies were mixed 
with RSV.  Magnetic particles and associated complexes were extracted and washed.  
A&C: Fluorescence and DIC images of unconjugated MMPs; B&D: Fluorescence and 
DIC images of MMPs conjugated to F-mix antibodies.  The striated patterns in the DIC 
images are thought to be due to the accumulation of MMPs along magnetic field lines 
(white arrows).  All images 20x (unpublished, Perez, et al.).   
 
 
A magnetic pulldown experiment shows that antibodies remain functional after 
attachment to MMPs (Figure 4).  After F-mix antibody conjugated MMPs were mixed 
with RSV, magnetic pulldown was used to extract bound virus.  Bound RSV was 
visualized by the addition of a fluorescent 655 nm quantum dot also attached to F-mix 
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antibodies.  Unbound quantum dot was removed by applying a magnetic field and 
washing.  In panel B, the fluorescence spots are due to the presence of the fluorescent 
quantum dot within the MMP-RSV complexes.  As a control, MMPs not conjugated to F-
mix antibody were also exposed to RSV, followed by the pulldown and addition of 
quantum dots.  Panel A shows the fluorescence image from this experiment which 
contains almost no fluorescence.  In panels C and D, the DIC images both show striations 
due to the MMPs lining up when a magnetic field is applied in the bottom right corner of 
both images.  The two large black spots in panel D are due to air bubbles. 
 
 
 
The maximum number of thiolated DNA strands (complementary to DNA logic 
tags) bound to a 15 nm diameter gold nanoparticle was found to be about 70 (Figure 5).  
Panel A shows the fluorescence measurement from the supernatant after FITC-labeled 
 
 
Figure 5. The maximum number of complementary thiolated DNA strands associated 
with each gold nanoparticle was determined using the methods illustrated in this figure.  
A. An increased concentration of FITC-labeled DNA logic tags coupled to gold 
nanoparticles (____) resulted in a difference in fluorescence intensity of the supernatant 
compared to FITC-labeled DNA alone (- - - -).  B: Number of strands bound per particle 
versus number of strands added per particle (unpublished data, Perez, et al.). 
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DNA is salt-aged with gold nanoparticles and the particles are spun out of solution.  For 
any given thiolated DNA concentration, the fluorescence is decreased in comparison to 
the same amount of DNA added to PBS alone.  The reduction in fluorescence suggests 
that DNA has attached to the gold nanoparticles.  Subtracting the amount of DNA found 
in the supernatant from what was originally added (from the fluorimeter readings) led to 
an estimation of the amount of DNA bound to particles (Panel B).  At low concentrations 
of DNA (less than 200 strands per particle), the number of tags per particle increases 
linearly with increases in initial DNA concentration.  Above ~200 strands, addition to the 
gold nanoparticles becomes non-linear and saturated, eventually reaching a plateau.   
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Figure 6. Time course of mass changes when balance-associated RSV was exposed to 
gold nanoparticles coupled to either DNA logic tags alone (grey line) or to DNA logic 
tags + Synagis (anti-RSV) antibody (black line).  RSV was flowed onto the quartz 
crystal, followed by a PBS wash.  Non-specific binding was blocked with 1% BSA.  
After excess BSA was washed with PBS, gold nanoparticles coupled to DNA logic tags 
and Synagis antibody were flowed onto the quartz crystal (black line).  Gold 
nanoparticles with DNA logic tags and no antibody served as a control (grey line, 
unpublished data, Perez, et al.) 
 
Gold nanoparticles conjugated to anti-RSV antibodies and DNA logic tags have a 
greater affinity for RSV than gold nanoparticles conjugated to DNA alone (Figure 6).  In 
this experiment, RSV was bound via hydrophobic interactions to the crystal on a 
microbalance.  This was followed by washing and blocking steps.  Gold nanoparticles 
with antibodies and DNA were then flowed along the crystal and along any bound RSV.  
Changes in mass alter the vibration of the crystal; these changes were measured using a 
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quartz crystal microbalance.  By comparing the addition of gold nanoparticles conjugated 
to antibodies and DNA to the addition of gold nanoparticles with DNA only, an increase 
in mass of about 0.03 µg was observed.  One 15 nm gold nanoparticle with a density of 
19,300 kg/m3 weighs ~3.4 x 10-11 µg.  Assuming that gold nanoparticles make up the 
majority of the weight of the gold nanoparticle-antibody-DNA complex, an increase of 
0.03 µg is equivalent to almost 900 million nanoparticles remaining on the crystal.  This 
suggests that the anti-RSV antibodies coupled to the gold nanoparticles are adhering to 
the RSV found on the crystal.  Also, gold nanoparticles with DNA alone do not seem to 
have much non-specific binding to RSV or BSA since an increase in mass is not seen.   
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 A plot of relative fluorescence against cycle number demonstrates that as few as 
10 copies of DNA logic tag T7-76 can be detected (Figure 7).  The results were gathered 
during a real-time PCR experiment using optimized concentrations of reagents, as well as 
temperature and time settings.  In particular, to achieve this sensitivity, it was necessary 
to measure fluorescence several degrees below the melting temperature of the specific 
product.  This step avoids fluorescence from primer dimers, which may be generated at 
high cycle numbers in samples with very few or no target sequences.  As expected, larger 
 
Figure 7. Results of a typical real-time PCR experiment for a range of initial copy numbers 
of DNA logic tag T7-76.  106 copies (- - - -) of initial template begin to amplify first and have a 
cycle threshold (Ct) value of 18.5 cycles ± 0.71 (mean ± s.d., n = 2); lower concentrations 
had lower Ct values (100 = 20.5 cycles ± 2.12 (_ _ _, n = 2), 10 = 21.5 cycles ± 0.71 (__ - -, n = 
2)).  The control with no initial template (____) does not reach the fluorescence level to 
generate a Ct value (n=1). 
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concentrations of initial DNA logic tag template result in lower cycle threshold (Ct) 
values.  106 copies result in a Ct value of 18.5 cycles ± 0.71 (mean ± s.d.); 100 and 10 
copies of DNA logic tags, 100 and 10, have lower Ct values: 20.5 cycles ± 2.12, 21.5 
cycles ± 0.71, respectively.   
 
 
 
200 bp 
  40 bp 
  1        2       3       4        5 
 
 
Figure 8. Agarose gel showing products of a typical PCR experiment for a range of 
template copy numbers.  Lane 1: no template (control), Lane 2: DNA ladder, Lane 3: 106 
copies, Lane 4: 102 copies, Lane 5: 10 copies.   
 
 The products from the PCR experiment in Figure 7 verified the formation of a 
single product at the expected product length of 76 base pairs (Figure 8).  Samples were 
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run on a 4% agarose gel at 120 V for 1 hour with SYBR Gold for visualization.  Melt 
curve analysis showed a gradual reduction in fluorescence with increases in temperature.  
For T7-76, a rapid fall off at 80°C indicated the presence of a specific product that melted 
at this temperature (data not shown).  Once the predicted length of 76 base pairs for T7-
76 had been confirmed by agarose gel electrophoresis, melt curve analysis was then used 
to identify specific products in subsequent analysis.  When comparing the product to the 
ladder, it shows up between 80 base pairs (bp) and 100 bp.  This shift of ~20 bp was 
routinely observed in our gels.  This is most likely due to SYBR Gold's interaction with 
DNA in the ladder, causing the ladder to move slower than other DNA.  Also, the 
increased brightness of 10 copies compared to 100 copies may be due to the use of ROX 
in the iTaq SYBR Green Supermix as an internal reference dye (bright band in all lanes 
right above product).  Its use may be hindering the level of brightness of the specific 
product in lane 4. 
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Figure 9. Summary of cycle threshold (Ct) values for a range of initial concentrations of 
DNA logic tag T7-76.  10 copies: Ct = 32.2 cycles ± 0.1 (mean ± s.d., n = 4); 102: Ct = 
28.1 cycles ± 2.8 (n = 2); 103 copies: Ct = 24.4 ± 1.6 (n=2); 106: Ct = 20 cycles ± 1.1 (n = 
10), 107 copies: Ct = 17.7 ± 0.4 (n=2). 
 
 
 Increasing concentrations of template copy number have decreasing cycle 
threshold (Ct) values (Figure 9).  This graph was generated by combining PCR results 
from various reactions.  Background from each sample was determined by averaging the 
fluorescence value of the first five cycles; this number was subtracted from all 40 cycles, 
spanning the entire PCR experiment.  Ct values were determined by finding the cycle at 
which the fluorescence reached 10 units.  100 and 10 copies were consistently amplified. 
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Figure 10.  Intact DNA logic tags remaining in solution after restriction enzyme cleavage 
can be amplified by PCR.  Ct values are as follows: Heat-Inactivated and No Enzyme: Ct 
= 6 cycles ± 1.4 (- - -, mean ± s.d., n=2), With Enzyme: Ct = 10 cycles ± 0.93 (- - - -, n=2); 
106 copies: Ct = 20 cycles ± 1.1 (- - -, n = 2); No Template: Ct = 38 cycles (____, n = 1). 
 
 
 Enzymatic cleavage of DNA logic tag and its complement reduces the 
fluorescence and Ct value observed with PCR (Figure 10).  This is presumably due to the 
reduction in template available for PCR amplification.  In the heat-inactivated enzyme, 
no enzyme, and with enzyme reactions, restriction complement DNA logic tag T7-76 and 
T7_RC-76 was added in a 5:1 ratio, 5x1013 copies and 1x1013 copies respectively.  This 
large number of copies was used so results could be visualized using agarose gel 
electrophoresis (Figure 11).  Cleavage of hybridized T7-76 and T7_RC-76 by restriction 
enzyme HpyCH4V for 1 hour at 37°C results in fewer strands of full-length T7-76, 
leading to a lower Ct value when amplified.  Heat inactivation was successful as the 
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addition of heat-inactivated enzyme (heated to 95°C for 30 minutes) does not seem to 
change the Ct value when compared to reactions where the same amount of T7-76 and 
T7_RC-76 were under the same conditions.  Also, addition of buffer supplied with the 
enzyme does not affect the outcome of PCR (data not shown). 
 
 1      2      3     4      5 
200 bp 
20 bp 
Hybridized T7-76 + T7_RC-76 
Cleaved Product 
T7-76 
 
 Restriction enzyme cleavage of T7-76 and its complement T7_RC-76 results in 
smaller pieces of DNA when compared to the same concentration of DNA not treated 
with enzyme (Figure 11).  Cleavage only seems to occur in the presence of DNA logic 
tag T7-76 and its complement (lane 1 vs. lane 3).  The agarose gel shows that T7-76 runs 
as a single band (lane 4).  The 20 bp DNA ladder in lane 5 is composed of double-
Figure 11. Agarose gel illustrating restriction enzyme cleavage of DNA logic tag T7-76 
and its complement T7_RC-76.  Lane 1: T7-76 + T7_RC-76 + restriction enzyme 
(HpyCH4V) + buffers; Lane 2: T7-76 + T7_RC-76 + heat-inactivated HpyCH4V + 
buffers; Lane 3: T7-76 + T7_RC-76 + buffers (no enzyme); Lane 4: T7-76 alone; Lane 5: 
DNA ladder.  4% agarose gel stained with SYBR Gold. 
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stranded DNA and, as such, cannot be used to indicate the absolute size of the single-
stranded DNA.  Adding T7_RC-76 in a 1:5 molar ratio with T7-76 (1x1013 copies and 
5x1013 copies respectively) results in a hybridization product that can be cleaved by the 
restriction enzyme HpyCH4V.  There is still a band corresponding to T7-76 since it was 
added in excess (lane 1).  Heat inactivation of HpyCH4V was successful and no cleavage 
of the hybridization product was observed (lane 2).  Further, restriction enzyme digestion 
is critically dependent on the presence of the tag and its corresponding restriction 
complement since no digestion was observed without the presence of the complement 
(lane 4).  From the design of T7-76 (Figure 3), we should see a band at 46 bp and 30 bp.  
While the band at 46 bp is difficult to see, a faint band at 30 bp is visible. 
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Figure 12. PCR results after magnetic pulldown experiment.  Pulldown in RSV (- - - -) had 
a cycle threshold (Ct) value of 14 (n=4); for 106 copies (_ _ _ , positive control for PCR), Ct 
= 18.75 ± 0.5 (mean ± s.d., n=4), for pulldown in PBS (__ - -), Ct = 22.75 ± 1.5 (n=4); for 
no template (____, negative control), Ct = 35.5 cycles ± 3.54 (n=2). 
The presence of RSV delivers DNA logic tags to the analyte solution after a 
magnetic pulldown experiment (Figure 12).  DNA logic tag T7-76 was separated from 
complementary strands conjugated to gold nanoparticles by applying a magnetic field and 
heat to a mixture of RSV, magnetic microparticles conjugated to anti-RSV antibodies, 
and gold nanoparticles conjugated to anti-RSV antibodies and DNA logic tags.  The 
DNA logic tags were then used in a PCR experiment and compared to the amplification 
of 106 copies of T7-76 as a positive control and the same magnetic pulldown run without 
RSV (in PBS) as a negative control.  The pulldown in RSV begins to amplify around 14 
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cycles, whereas the pulldown in PBS amplifies at around 22.75 cycles.  This difference in 
Ct values implies that there is more T7-76 delivered from the pulldown in RSV than from 
the pulldown in PBS, suggesting that magnetic microparticles and gold nanoparticles 
bind RSV and that DNA logic tags are delivered to the analyte solution by magnetic 
pulldown.  The amplification of pulldown in PBS (without RSV) suggests that non-
specific binding events also occur which leads to delivery of less, but a significant 
number of DNA logic tags. 
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Figure 13. Restriction enzyme cleavage after magnetic pulldown decreases the number 
of initial template for PCR amplification.  For pulldown in RSV, cycle threshold value 
(Ct) = 12.2 ± 0.12 (mean ± s.d., n = 2); after cleavage, Ct = 14.3 ± 0.42 (n=2).  For 
pulldown in PBS, Ct = 19.8 ± 0.28; after cleavage, Ct = 24 ± 0.57.  Ct value for the 
negative was 36 (n = 1). 
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 Restriction enzyme cleavage on a solution of T7-76 and T7_RC-76 from 
magnetic pulldown in the presence or absence of RSV decreases the number of templates 
used for PCR amplification (Figure 13).  After magnetic pulldown, the analyte solution 
was treated with restriction enzyme (HpyCH4V) with buffer and incubated for 1 hour.  
PCR was run on both the original aliquot from the pulldown and the enzyme-treated 
solution.  From these results, restriction enzyme cleavage has led to a 2-5 increase in Ct 
value.  This is most likely due to a decrease in full-length template for amplification by 
PCR.  Interestingly, the level of fluorescence for the two enzyme-treated aliquots is much 
lower than that of the original solutions.  This may be due to the presence of enzyme and 
buffer in solution.  It may also be the result of primers attaching to primer sites from 
pieces of DNA from the restriction enzyme cleavage, leading to the amplification of 
product of less length (Figure 3). 
 
Discussion 
The goal of these experiments was to design and evaluate the key components of 
a new antibody-based detection platform.  In preliminary experiments shown in Figure 
13, the basic expected outcome was demonstrated: the application of a NOT operation 
carried out by restriction enzyme cleavage on DNA logic tags led to a lower amount of 
fluorescence generated by PCR.  This result was dependent on experimental validation of 
each component of the platform's design: coupling of antibody to magnetic 
microparticles, coupling of antibody to gold nanoparticles, coupling of DNA logic tags 
and its complementary thiolated sequence to gold nanoparticles, PCR amplification of 
DNA logic tags, cleavage of DNA logic tag and its restriction complement, and release of 
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tags from beads.  These components supported the approach we set out to explore in 
Figure 1 and Figure 2. 
We examined the effect of coupling F-mix (polyclonal anti-RSV) antibodies to 
magnetic microparticles in order to verify their functionality.  In Figure 4, a mock 
magnetic pulldown experiment was performed where the gold nanoparticle in our design 
was replaced with a fluorescent 655 nm quantum dot for visualization.  Comparing panel 
A without conjugated antibodies to panel B with conjugated antibodies, we determined 
that the antibody was functional and was binding to RSV.  Next, we had to ensure that 
antibodies could retain their functionality when conjugated to gold nanoparticles (Figure 
6).  By letting antibody-conjugated gold nanoparticles bind RSV on a quartz crystal 
microbalance, we observed changes in mass over time, presumably due to antibodies on 
gold nanoparticles binding to virus.  To confirm that thiolated sequences complementary 
to DNA logic tags could also be coupled to gold nanoparticles, we looked at fluorescently 
labeled DNA strands and compared the amount remaining in supernatant after salt aging 
with and without gold nanoparticles (Figure 5).  Conjugating 70 strands of thiolated DNA 
complementary to the DNA logic tags allowed us to hybridize around 40 DNA logic tags 
to each gold nanoparticle (data now shown). 
One concern of co-conjugating antibodies and DNA on gold nanoparticles is that 
if the DNA is too long, it could hinder antibody functionality.  Originally, DNA logic 
tags were smaller, around 40 bp; a thiolated 40-mer DNA strand was to be coupled to 
gold nanoparticles.  As gold nanoparticles and DNA are inherently sticky, the appropriate 
spacer needed to be added to the thiolated strand to prevent DNA from sitting on the 
surface of the gold nanoparticle and to provide maximum surface area for antibody 
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conjugation.  Among the four nucleic acids, a 15-mer thymine spacer was used based on 
literature to provide the necessary barrier between the gold nanoparticles and DNA, 
increasing the thiolated strand from a 40-mer to a 55-mer.39  From our initial results, this 
length did not interfere with antibody conjugation or functionality (QCM tests, similar to 
Figure 6, data not shown).  Due to the constraints on commercial synthesis of DNA, the 
upper limit for a DNA logic tag was 120 bp.  From experiments with 120-mer DNA 
strands (120 + 15 T-spacer), we determined that antibody functionality was not 
diminished with DNA of that length (data not shown). 
To ensure that our PCR application in itself was sensitive, we tested the lower 
limits of detection.  We were able to amplify 10 copies of DNA logic tags with a 
significant difference compared to the no template negative control (Figure 7).  By 
running the product on agarose gels, we could also determine that one specific product 
was being made from various initial template concentrations (Figure 8).  This outcome 
convinced us that DNA logic tags were being amplified when a positive result had a 
melting temperature of 80°C.  Finally, combining the results from different PCR 
experiments showed consistency in discriminating a range of initial template copy 
numbers from the no template (negative) control. 
A TaqMan probe site was designed for all ten DNA logic tags (Table 1).  
However, in these initial experiments, the intercalating dye SYBR Green was used 
instead.  Using TaqMan probes would have increased our specificity and decreased our 
detection of primer dimers.  But, using it could have also decreased the amount of 
fluorescence generated during each amplification cycle.  On the other hand, SYBR Green 
binds to all double-stranded DNA with a preference for G+C regions.40  These properties 
 57
allow for a quick check of any double-stranded product formed during our PCR 
experiments.  Furthermore, purchasing the necessary TaqMan probes for each DNA logic 
tag designed would have increased our initial costs.  Instead, DNA logic tags were 
decided from SYBR Green experiments.  Experiments are underway with the TaqMan 
probe corresponding to DNA logic tag T7-76 to determine if specificity is increased and 
what effect, if any, its use has on sensitivity.  Also, we will need to determine if the 
incorporation of uracil instead of thymine will have an impact on the binding of the 
TaqMan probe. 
One discrepancy we noticed during our PCR experiments was that 10-fold 
changes in initial DNA logic tag concentration did not correspond to a displacement of 
~3.3 PCR cycles.  This difference is generally seen in PCR experiments because if we 
assume each cycle doubles the amount of DNA, then 2(3.3 cycles) = 10-fold difference.14  In 
fact, as seen in Figure 9, starting with 102 copies results in a Ct value of 28.1 ± 2.8 (mean 
± s.d.); for 10 copies, the Ct value is 32.2 ± 0.1.  A 10-fold lower concentration led to a 4-
cycle difference.  This could be due to the settings of the reaction or the type of DNA 
polymerase used.  We will need to ascertain the efficiency of our polymerase by running 
further tests to improve the reactions and to optimize the difference in Ct values among 
varying concentrations of starting template. 
Another problem we found was that our product did not line up with the correct 
molecular weight on the DNA ladder; this 20 bp shift between ladder and product was 
observed with all DNA logic tags and with different lots of ladder from the same 
manufacturer (Figure 8 and Figure 11).  To remedy this, we will first test other stains.  
Ethidium bromide is generally used to stain gels; however, due to its increased toxicity 
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and lower sensitivity, it was not used in this application.  But, it is possible that it would 
not have as great of an effect on DNA migration as SYBR Gold.  Also, post-staining the 
gel instead of adding the stain directly to the DNA could solve this problem because the 
dye would not affect DNA migration.  We will also explore using ladders from different 
manufacturers. 
Next, we determined that restriction enzyme cleavage by the enzyme HpyCH4V 
led to degradation of T7-76 and its complement.  First, we had carefully designed logic 
tag T7-76 and T7_RC-76 to contain a site for restriction enzyme digestion (Figure 3, 
Table 1).  We first ran agarose gels with large amounts of logic tag and its complement to 
observe degraded product (Figure 11).  Next, we ran PCR on lower concentrations of 
product to find that there was a decrease in the amount of usable templates when 
HpyCH4V was first applied (Figure 10). 
Finally, we demonstrated that the solution phase complex of magnetic 
microparticles conjugated to antibodies and gold nanoparticles conjugated to antibodies 
and DNA logic tags can be used to bind virus and deliver DNA logic tags to an analyte 
solution.  When PCR was performed after a virus pulldown, DNA logic tags could be 
amplified (Figure 12).  Furthermore, there was a significant difference between the 
amounts of DNA logic tags that were amplified from a virus pulldown versus a pulldown 
that did not contain virus (in PBS).  The PCR results also showed that non-specific 
binding or the generation of false positives is inherent within this antibody-based 
detection strategy.  When the magnetic pulldown was performed in PBS alone, template 
was still delivered, most likely due to unbound gold nanoparticles remaining in solution 
during separation and washing steps.  This solution contained DNA logic tag T7-76 and 
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amplified well above the negative control that contained no template (Figure 12).  If we 
had not seen this result, non-specific binding would probably still occur when the 
pulldown is run in cell lysate.  We could verify this by running a magnetic pulldown with 
non-specific antibody and then running PCR on the output with primers designed for 
T7_RC-76; if amplification does occur, it would be due to non-specific binding.   
One aspect of DNA logic tag delivery is how to release the logic tags from the 
magnetic pulldown.  In the current design, thiolated strands are conjugated to the gold 
nanoparticle with DNA logic tags hybridized directly to them.  They are then released by 
heating.  Another method for releasing DNA logic tags is to directly conjugate them to 
the gold nanoparticles and then release them using DTT.  This difference may lead to an 
increased number of DNA logic tags associated to each gold nanoparticle and, in turn, to 
each virus or pathogen.  However, there could also be a negative effect of DTT on the 
efficiency of the following restriction enzyme and PCR experiments.  Another aspect of 
DNA logic tag delivery is the possibility that subsequent PCR processes may amplify a 
part of the cell lysate.  When designing logic tags for a specific detection application, a 
BLAST search should also be done against the genome of the pathogen of interest. 
These preliminary results suggest that this is a feasible and promising application 
to reduce the number of DNA logic tags that result from non-specific antibody binding.  
Certain factors remain to be studied, for example, the optimal parameters for the 
restriction enzyme cleavage reaction as well as the limits of sensitivity and specificity of 
the NOT operation.  Experiments to examine these aspects are underway. 
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 CHAPTER III 
 
FUTURE DIRECTIONS 
 
 Although the research described here deals with the detection of a specific test 
virus (RSV), we believe similar results will be seen with other viruses and molecular 
structures that can be selectively bound by antibodies. 
 Within this present application, parameters of restriction enzyme cleavage, such 
as incubation times and enzyme concentration, after magnetic pulldown still need to be 
optimized.  Also, various limits remain to be tested.  First, the limits of restriction 
cleavage need to be explored.  In particular, we would like to know at what concentration 
of DNA logic tags associated to non-specific binding events do cleavage reactions 
become ineffective.  Also, we would like to examine the constraints of the system by 
looking at how low and high concentrations of virus affect the outcome.  Finally, we 
would like to test the upper and lower limits of sensitivity and specificity of our 
application. 
 We would also like to explore the use of other logical operations AND and OR.  
The AND operation may be beneficial in decreasing the presence of false positives by 
requiring two or more binding events to occur in order to produce a signal.  Two different 
DNA logic tags and two different monoclonal antibodies would be coupled to gold 
nanoparticles.  Similar to the NOT operation, the different tags will be delivered to an 
analyte solution.  Next, ligation templates or small pieces of DNA complementary to the 
ends of the tags will be added.  After they hybridize, DNA ligase will be used to ligate 
the ends of the logic tags, creating one large strand of DNA.  During PCR, primers 
specific to only this large strand would be added.  Any signal would be the result of 
amplification of the ligated DNA strand and would be associated with two specific 
binding events, increasing the certainty of the output by decreasing the rate of false 
positives. 
 The logical OR operation is another application of this general design.  For the 
OR operation, different tags associated with different antibodies coupled to gold 
nanoparticles will be delivered to an analyte solution.  During PCR, primers to all of 
these logic tags will be added as well as the corresponding TaqMan probes with different 
fluorophores, which will allow for analysis of different tags in parallel.  This approach 
could especially be important in detection of molecular markers in diseases like cancer 
where there is an interplay between which markers are present and in what 
concentrations. 
 Another manipulation of this design is to conjugate DNA strands instead of 
antibodies onto the gold nanoparticles to create a detection method for patterns of 
biomarkers.  These DNA strands could be complementary to DNA and RNA.  By 
associating DNA logic tags with DNA, RNA, and proteins, another molecular patterning 
strategy can be implemented to see if all three are present in solution (AND) and if there 
are any differences in concentration among the different biomarkers (OR). 
 Additionally, we would like to add a quantitative approach to all of these 
operations which would allow us to describe the amount of antigen present in solution by 
only looking at the results of PCR.  Furthermore, we would like to produce mathematical 
relationships to describe the results of these operations.  For example, for the NOT 
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reaction, we could form relationships that describe the use of specific and non-specific 
antibodies in comparison to using specific antibodies alone. 
A variety of detection techniques could benefit from this design, everything from 
the detection of virus to biomarker patterns to biological threat agents.  We believe that 
this strategy utilizes well-established molecular biology techniques using DNA as inputs 
to logical operations in order to increase accuracy, precision, sensitivity, and specificity 
of detection applications. 
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